Provided by Tiger Trade Technology Pte. Ltd.

SciSparc Ltd.

0.4751
-0.0251-5.02%
Volume:53.30K
Turnover:25.79K
Market Cap:2.07M
PE:-0.02
High:0.5099
Open:0.5099
Low:0.4750
Close:0.5002
52wk High:10.82
52wk Low:0.4621
Shares:4.35M
Float Shares:3.77M
Volume Ratio:1.04
T/O Rate:1.41%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-22.6549
EPS(LYR):-22.6549
ROE:-1281.49%
ROA:-42.05%
PB:--
PE(LYR):-0.02

Loading ...

SciSparc to Acquire Controlling Interest in Miza III Ventures, Transferring Pharmaceutical Portfolio in $11.6M Deal

Reuters
·
Oct 15, 2025

Scisparc Ltd - Expected to Hold 75%-84% Controlling Interest in Miza

THOMSON REUTERS
·
Oct 15, 2025

Scisparc Ltd - Assets and Equity Stake Valued at $11.6 Mln

THOMSON REUTERS
·
Oct 15, 2025

Scisparc Enters Into Definitive Agreement for the Acquisition of a Publicly Traded Company on the Tsxv to Which It Will Transfer Its Advanced Clinical Stage Pharmaceutical Portfolio

THOMSON REUTERS
·
Oct 15, 2025

Press Release: SciSparc Enters into Definitive Agreement for the Acquisition of a Publicly Traded Company on the TSXV to which it will transfer its Advanced Clinical Stage Pharmaceutical Portfolio

Dow Jones
·
Oct 15, 2025

BRIEF-Scisparc Ltd. announces framework agreement regarding merger with automax motors

Reuters
·
Oct 06, 2025

SciSparc Ltd. and AutoMax Motors Amend Loan Agreements Following Termination of Merger, Establish New Repayment Terms

Reuters
·
Oct 06, 2025

Scisparc Ltd. Announces Framework Agreement Regarding Merger With Automax Motors

THOMSON REUTERS
·
Oct 06, 2025

Scisparc Ltd - Terminates Merger With Automax Motors

THOMSON REUTERS
·
Oct 06, 2025

BUZZ-U.S. STOCKS ON THE MOVE-Robinhood, Firefly Aerospace, Coty

Reuters
·
Sep 30, 2025

BUZZ-SciSparc jumps on deal to spin off cancer drug unit

Reuters
·
Sep 30, 2025

N2OFF shareholders approve acquisition of SciSparc subsidary

TIPRANKS
·
Sep 30, 2025

N2OFF Shareholders Approve Acquisition of SciSparc’s MitoCareX Subsidiary, Paving Way for Completion in October 2025

Reuters
·
Sep 30, 2025

Scisparc: N2off Shareholders Approve Merger With Scisparc’s Majority Owned Subsidiary Mitocarex, a Drug Discovery Company Targeting Resistant Cancers Including Pancreatic and Non-Small Cell Lung Cancer

THOMSON REUTERS
·
Sep 30, 2025

N2OFF Shareholders Approve Acquisition of MitoCareX Bio

MT Newswires Live
·
Sep 26, 2025

N2OFF Stockholders Approve Merger with Drug Discovery Company Targeting Resistant Cancers Including Pancreatic and Non-Small Cell Lung Cancer

GlobeNewswire
·
Sep 26, 2025

SciSparc Stock Surges As It Launches Initiative To Advance Drug Discovery With Quantum Algorithms

Benzinga
·
Sep 26, 2025

SciSparc initiate launch of 3D protein modeling initiative

TIPRANKS
·
Sep 25, 2025

Why SciSparc (SPRC) Stock Is Skyrocketing Today

Benzinga_recent_news
·
Sep 17, 2025

Scisparc Shares More Than Double in Value to $4.2; Automax Motors Files Motion in Jerusalem Court Regarding Merger With Co

THOMSON REUTERS
·
Sep 17, 2025